Its cytotoxicity was mainly effective in TP53‐mutated or PTEN‐deleted lymphomas strengthening the hypothesis of AF repurposing for treatment of TP53‐mutated or PTEN‐deleted refractory B‐cell lymphoma. This evidence concerns the gene PTEN and lymphoma.